Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: January 12, 2026
Reporting Period: This filing reports on events occurring on January 12, 2026, specifically regarding upcoming investor presentations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure notice rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed in the text of this filing. The report focuses solely on the disclosure of an investor presentation.
Guidance, Outlook, and Management Commentary
- Item 7.01 (Regulation FD Disclosure): Executive officers have scheduled upcoming presentations for investors and analysts.
- Exhibit 99.1: The company intends to use an investor presentation dated January 20, 2026, as part of these communications.
- Legal Status: The information in this Item 7.01 and the referenced Exhibit 99.1 is furnished, not "filed," for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless expressly stated otherwise.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (Investor Presentation dated January 20, 2026) for specific financial guidance or strategic updates, as the 8-K text only references it.
- Confirm the schedule of upcoming investor presentations mentioned by executive officers.
- Note that the information provided in this specific 8-K is not legally "filed" under Section 18 of the Exchange Act.